Plague Vaccine Development: Current Research and Future Trends.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

1. Live Plague Vaccine Development: Past, Present, and Future.Vaccines · 2025
   Review
2. Progress on the research and development of plague vaccines with a call to action.NPJ vaccines · 2024
   Review
3. Isolation of camel single domain antibodies against Yersinia pestis V270 antigen based on a semi-synthetic single domain antibody library and development of a VHH-based lateral flow assay.Veterinary medicine and science · 2024
   Article
4. Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.Frontiers in immunology · 2024
   Article
5. Antimicrobial therapies administrated during the Third Plague Pandemic in Europe.Le infezioni in medicina · 2024
   Article
6. New Bacteriophages with Podoviridal Morphotypes Active againstViruses · 2023
   Article
7. Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice.Frontiers in immunology · 2022
   Article
8. Complete Protection AgainstFrontiers in immunology · 2022
   Article
9. The magnitude of the germinal center B cell and T follicular helper cell response predicts long-lasting antibody titers to plague vaccination.Frontiers in immunology · 2022
   Article
10. Plague vaccines: new developments in an ongoing search.Applied microbiology and biotechnology · 2021
    Review
11. Broadly reactive human CD4European journal of immunology · 2021
    Article
12. Protection Elicited by Attenuated LiveVaccines · 2021
    Article
13. Biomolecules · 2020
    Review
14. Human plague: An old scourge that needs new answers.PLoS neglected tropical diseases · 2020
    Review
15. Optimization and One-Step Purification of Recombinant V Antigen Production from Yersinia pestis.Molecular biotechnology · 2020
    Article
16. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.Frontiers in immunology · 2020
    Article
17. Vaccines for emerging pathogens: prospects for licensure.Clinical and experimental immunology · 2019
    Review
18. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.Vaccine · 2019
    Article
19. Infection and immunity · 2019
    Article
20. Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target.EcoSal Plus · 2019
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as